Disclosures for "Therapeutic Efficacy and Safety of Onasemnogene Abeparvovec Gene Therapy for Spinal Muscular Atrophy Type 1: Updated Systematic Review with Meta-analysis"
-
Dr. Hanen has nothing to disclose.
-
Dr. Alfaqaih has nothing to disclose.
-
Hazem Mohammed has nothing to disclose.
-
Dr. Nasser has nothing to disclose.
-
Dr. Haseeb has nothing to disclose.
-
Dr. Yaser has nothing to disclose.
-
Dr. yasser has nothing to disclose.
-
Dr. Darwish has nothing to disclose.
-
Dr. Meshref has nothing to disclose.